Stricter Norms for Assisted Reproductive Technology Clinics
By Kounteya Sinha,
The Times of India
| 04. 12. 2012
JAIPUR: All clinics in India, involved in treating infertility through procedures like artificial insemination with husband's semen (AIH) or in-vitro fertilization-embryo transfer (IVF), will now have to get registered in the country's first National Registry of Assisted Reproductive Technology (ART) clinics in India.
In order to regulate the ART trade in India, the Union health ministry and the Indian Council of Medical Research (ICMR) are setting up the Registry "with a view to providing appropriate help and assistance to all those who are engaged in taking care of infertility problems in the country."
All clinics practicing techniques such as Artificial Insemination with Donor Semen (AID), Gamete Intrafallopian Tube Transfer (GIFT), Tubal Embryo Transfer (TET), Intracytoplasmic Sperm Injection (ICSI), Testicular Sperm Aspiration (TESA), Testicular Sperm Extraction (TESE) or processing or storage of gametes (sperm and oocyte) and or embryos will have to be part of the Registry.
Each registrant will be given a unique registration number by the ICMR that could be used by the registrant for any legitimate purpose.
ICMR estimates that 15% of couples around the world are infertile...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...